LogiPharma’s 2026 agenda is taking shape around three core themes: supply chain resilience, practical artificial intelligence applications, and fresh peer engagement formats.
The pharmaceutical supply chain sector has faced mounting pressure in recent years, forcing companies to rethink long-standing operational playbooks built up over decades.
Industry leaders are increasingly moving beyond theoretical AI discussions, demanding sessions that demonstrate real-world deployment and measurable results within their supply chains.
LogiPharma’s Charleen Ring has been among those helping to shape the 2026 agenda, prioritising content that reflects where pharmaceutical logistics professionals actually are in their transformation journeys.
McKesson’s Chris Van Norman is also contributing to the programme, with both figures set to appear in a fireside chat scheduled for day two of the event.
The fireside chat format is designed to encourage candid, unscripted conversation between senior executives, moving away from polished presentations toward genuine peer exchange.
New peer formats are a deliberate addition to the 2026 agenda, reflecting feedback from attendees who want more structured opportunities to learn directly from counterparts facing similar challenges.
Resilience has become a defining concern for pharmaceutical supply chain leaders following disruptions that exposed vulnerabilities in global distribution networks and inventory strategies.
Organisations like McKesson, one of the largest healthcare distribution companies in the United States, are central voices in conversations about how the industry rebuilds and future-proofs its operations.
The sessions flagged for prioritisation at LogiPharma 2026 reflect a broader industry shift, where execution and adaptability are valued far more than long-term strategic frameworks that have failed to anticipate rapid change.
Delegates attending the event can expect a programme built around actionable insights, with speakers drawing on direct operational experience rather than purely advisory or consultancy perspectives.
The combination of resilience strategy, AI implementation guidance, and redesigned networking formats positions LogiPharma 2026 as a significant moment for pharmaceutical supply chain professionals seeking practical direction.